Adults treated with 14 days of intravenous injections of ginkgo diterpene lactone meglumine (GDLM) -- a combination of biologically active components of ginkgo biloba -- after an ischemic (clot-caused ...
Relationship between the active components of NRK-C and targets in the prevention and treatment of diabetes. (A−intersection of NRK-C active components and diabetes-related target points.